Online citations, reference lists, and bibliographies.
← Back to Search

Incidence And Survival Of Mesothelioma In Osaka, Japan.

Naoko Kanazawa, A. Ioka, H. Tsukuma, W. Ajiki, A. Oshima
Published 2006 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
BACKGROUND Mortality statistics show rapid increase in the number of deaths from mesothelioma. However, population-based study of the incidence and the survival has never been conducted. Time-trends and regional differences in the incidence of mesothelioma in Osaka were examined together with their 5-year survival. METHODS Individual data for mesothelioma were retrieved from Osaka Cancer Registry during the period 1966-2001. Annual incidence rates were calculated for every 3 years from 1975 to 2001, and age-standardized rates were calculated with the Japanese model population of 1985. Standardized incidence ratios were also calculated by age-specific number of population of each municipality and the corresponding age-specific incidence rates of mesothelioma in Osaka Prefecture during the period 1981-2001. The survival analysis was performed with the Kaplan-Meier method, based on the newly reported cases diagnosed during the period 1975-1997. RESULTS Incidence rates of mesothelioma have increased rapidly both among males and females in Osaka during the past few decades. Geographical differences in the standardized incidence ratios were found to be remarkable in Osaka Prefecture. The result shows that the survival of malignant mesothelioma was very poor (5-year survival and median survival time: 5.1% and 6 months for males, 10.2% and 5 months for females). CONCLUSIONS Incidence of mesothelioma has increased remarkably in Osaka, Japan, during past few decades. Geographical variations in the incidence were also suggested. Five-year survival of the patients was very poor.
This paper references



This paper is referenced by
10.1111/j.1349-7006.2011.02126.x
ZDHHC8 knockdown enhances radiosensitivity and suppresses tumor growth in a mesothelioma mouse model
H. Sudo (2012)
10.1097/MNM.0b013e328336733d
Development of positron emission tomography imaging by 64Cu-labeled Fab for detecting ERC/mesothelin in a mesothelioma mouse model
C. Yoshida (2010)
10.1183/09031936.00000811
Predicting survival in malignant mesothelioma
A. Musk (2011)
10.1016/j.nucmedbio.2009.01.018
Comparison of conventional and novel PET tracers for imaging mesothelioma in nude mice with subcutaneous and intrapleural xenografts.
A. Tsuji (2009)
10.1007/s00280-010-1503-x
The therapeutic efficacy of S-1 against orthotopically implanted human pleural mesothelioma cells in severe combined immunodeficient mice
Trung The Van (2010)
10.1007/s00408-013-9516-y
Stratification of Malignant Pleural Mesothelioma Prognosis Using Recursive Partitioning Analysis
H. Suzuki (2013)
10.1002/ccr3.371
Rapidly progressive sarcomatoid malignant mesothelioma of the pleura mimicking pulmonary empyema
K. Fujita (2015)
10.1111/j.1349-7006.2009.01463.x
Antitumor activity of anti‐C‐ERC/mesothelin monoclonal antibody in vivo
K. Inami (2010)
10.1183/09031936.00168111
Mesothelioma incidence projections in South East England
S. P. Riaz (2012)
10.1007/s00595-008-3776-9
Diffuse malignant pleural mesothelioma: A multi-institutional clinicopathological study
A. Iyoda (2008)
10.1097/CEJ.0b013e3282f0c0a2
US mesothelioma patterns 1973–2002: indicators of change and insights into background rates
M. J. Teta (2008)
Uncovering geographic concentrations of elevated mesothelioma risks across Japan : Spatial epidemiological mapping of the asbestos-related disease
Tomoki Nakaya (2015)
10.1093/jjco/hyq159
Survival and prognostic factors in malignant pleural mesothelioma: a retrospective study of 314 patients in the west part of Japan.
S. Nojiri (2011)
10.1159/000100446
Blood Tests for Asbestos-Related Mesothelioma
M. Maeda (2006)
10.1289/ehp.0900868
Are Current or Future Mesothelioma Epidemics in Hong Kong the Tragic Legacy of Uncontrolled Use of Asbestos in the Past?
L. A. Tse (2010)
Establishment of an Asian Cancer Registry Network - problems and perspectives.
M. A. Moore (2008)
Stratification of Malignant Pleural Mesothelioma Prognosis Using
Hidekazu SuzukiKazuhiro (2014)
10.1002/ijc.23874
Survival of pleural malignant mesothelioma in Italy: A population‐based study
F. Montanaro (2009)
10.1002/ijc.24711
Evolution of pleural cancers and malignant pleural mesothelioma incidence in France between 1980 and 2005
N. Le Stang (2010)
10.3844/ajeassp.2018.1310.1319
Identification of Cancer - Mesothelioma Disease Using Logistic Regression and Association Rule
Avishek Choudhury (2018)
10.1016/j.canep.2013.12.002
Malignant pleural mesothelioma incidence and survival in the Republic of Ireland 1994-2009.
C. J. Jennings (2014)
10.2169/INTERNALMEDICINE.51.6236
Prognostic factors in malignant pleural mesothelioma: a retrospective study.
H. Suzuki (2012)
10.4137/CCRPM.S577
Immunological Changes in Mesothelioma Patients and Their Experimental Detection
M. Maeda (2008)
10.3892/ijo.2013.2183
AHNAK is highly expressed and plays a key role in cell migration and invasion in mesothelioma.
H. Sudo (2014)
10.1016/j.ygeno.2010.02.002
Knockdown of COPA, identified by loss-of-function screen, induces apoptosis and suppresses tumor growth in mesothelioma mouse model.
H. Sudo (2010)
A retrospective study of chemotherapy with and without pemetrexed in malignant pleural mesothelioma.
M. Higashiguchi (2012)
10.1111/gtc.12599
Critical role of the Ror‐family of receptor tyrosine kinases in invasion and proliferation of malignant pleural mesothelioma cells
Takeshi Saji (2018)
Genes to Cells
Saki Inuzuka (2018)
10.5795/JJSCC.48.159
Hematoxylin S solution を用いたセルブロック法の有用性
実 大橋 (2009)
10.1002/cyto.a.22602
Detection of malignant mesothelioma using nuclear structure of mesothelial cells in effusion cytology specimens
A. B. Tosun (2015)
Semantic Scholar Logo Some data provided by SemanticScholar